N-(1-苄基哌啶-4-基)-2-苯基乙酰胺 | 132862-06-7

• 分子结构分类: 有机化合物 - 有机杂环化合物 - 哌啶类
• 中文名称: N-(1-苄基哌啶-4-基)-2-苯基乙酰胺
• 英文名称: N-(1-benzylpiperidin-4-yl)phenylacetamide
• 英文别名: N-(1-benzylpiperidin-4-yl)-2-phenylacetamide
• CAS: 132862-06-7
• 化学式: C₂₀H₂₄N₂O
• 分子量: 308.423
• InChiKey: DCWZTDBABTVENH-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  3.2
• 重原子数：
  23
• 可旋转键数：
  5
• 环数：
  3.0
• sp3杂化的碳原子比例：
  0.35
• 拓扑面积：
  32.3
• 氢给体数：
  1
• 氢受体数：
  2

反应信息

• 作为反应物：
  描述：

  N-(1-苄基哌啶-4-基)-2-苯基乙酰胺 在 palladium dihydroxide 氢气 作用下， 以 甲醇 为溶剂， 反应 12.0h， 以90%的产率得到4-phenylacetamidopiperidine
  参考文献：
  名称：

  N-（1-苄基哌啶-4-基）芳基乙酰胺类似物作为有效的sigma1受体配体的合成与构效关系。

  摘要：

  合成了一系列N-（1-苄基哌啶-4-基）芳基乙酰胺，并评估了它们与sigma1和sigma2受体的结合特性。与先前报道的N-（1-苄基哌啶-4-基）苯基乙酰胺的sigma1 / sigma2受体结合数据一致，下面报告的所有N-（1-苄基哌啶-4-基）芳基乙酰胺化合物均显示出对sigma1的亲和力高于sigma2受体。用噻吩，萘基或吲哚芳环取代苯乙酰胺部分的苯环对sigma1受体的亲和力没有明显影响。用咪唑或吡啶基芳环取代苯环会导致对sigma1受体的亲和力损失> 60倍，并且对sigma2受体的结合亲和力不明显。苄基芳香环上的取代显示出对sigma1受体的亲和力相似或略有降低。苯乙酰胺部分和苄基上的芳香环都被卤素取代，导致对sigma（1）受体的亲和力相似，并且对sigma2受体的亲和力大大提高。比较分子场分析表明，苯乙酰胺芳环中取代基的静电性质强烈影响与sigma1受体的结合。化合物1、

  DOI：

  10.1021/jm010384j
• 作为产物：
  描述：

  苯乙酸 、 4-氨基-1-苄基哌啶 在 1-羟基苯并三唑 、 盐酸-N-乙基-Nˊ-(3-二甲氨基丙基)碳二亚胺 作用下， 以 乙腈 为溶剂， 反应 18.5h， 生成 N-(1-苄基哌啶-4-基)-2-苯基乙酰胺
  参考文献：
  名称：

  COMPOUNDS USEFUL IN THE TREATMENT OF INFLAMMATORY DISEASES

  摘要：

  公开号：

  EP1140837B1

文献信息

• Selective cellular targeting: multifunctional delivery vehicles, multifunctional prodrugs, use as antineoplastic drugs
  申请人：Drug Innovation & Design, Inc.

  公开号：US20030138432A1

  公开（公告）日：2003-07-24

  The present invention relates to the compositions, methods, and applications of a novel approach to selective cellular targeting. The purpose of this invention is to enable the selective delivery and/or selective activation of effector molecules to target cells for diagnostic or therapeutic purposes. The present invention relates to multi-functional prodrugs or targeting vehicles wherein each functionality is capable of enhancing targeting selectivity, affinity, intracellular transport, activation or detoxification. The present invention also relates to ultra-low dose, multiple target, multiple drug chemotherapy and targeted immunotherapy for cancer treatment.

  本发明涉及一种新的选择性细胞靶向的组合物、方法和应用。本发明的目的是为了实现对目标细胞的选择性输送和/或选择性激活效应分子，以进行诊断或治疗。本发明涉及多功能前药或靶向载体，其中每个功能都能增强靶向选择性、亲和力、细胞内转运、激活或解毒。本发明还涉及超低剂量、多靶点、多药物化疗和靶向免疫疗法，用于癌症治疗。
• Aminoazacycloalkanes as CCR5 modulators
  申请人：PFIZER INC.

  公开号：EP1013276A1

  公开（公告）日：2000-06-28

  Compounds of Formula 1         [Region α]-[Region β]-[Region γ] [Region δ]     (I) which are useful as modulators of chemokine activity. The invention also provides pharmaceutical formulations and methods of treatment using these compounds.

  式 1 的化合物 [区域 α]-[区域 β]-[区域 γ] [区域 δ] (I) 可用作趋化因子活性调节剂。本发明还提供了使用这些化合物的药物制剂和治疗方法。
• Synthesis and Quantitative Structure−Activity Relationships of <i>N</i>-(1-Benzylpiperidin-4-yl)phenylacetamides and Related Analogues as Potent and Selective σ₁ Receptor Ligands
  作者：Yunsheng Huang、Philip S. Hammond、Brian R Whirrett、Ross J. Kuhner、Li Wu、Steven R. Childers、Robert H. Mach

  DOI：10.1021/jm980032l

  日期：1998.6.1

  A series of N-(1-benzylpiperidin-4-yl)pherlylacetamide derivatives was synthesized and evaluated for affinity at or and oz receptors. Most of these compounds showed a high affinity for sigma(1) receptors and a low to moderate affinity for sigma(2) receptors. The unsubstituted compound N-(1-benzylpiperidin-4-yl)phenylacetamide, 1, displayed a high affinity and selectivity for sigma(1) receptors (K-i) values of 3.90 nM for sigma(1) receptors and 240 nM for sigma(2) receptors. The influence of substitutions on the phenylacetamide aromatic ring on binding at both the sigma(1) and sigma(2) receptor has been examined through Hansch-type quantitative structure-activity relationship (QSAR) studies. In general, all 3-substituted compounds, except for the OH group, had a higher affinity for both sigma(1) and sigma(2) receptors when compared with the corresponding 2- and 4-substituted analogues. The selectivity for sigma(1) receptors displayed a trend of 3 > 2 approximate to 4 for Cl, Pr, F, NO2, and OMe substituted analogues. Halogen substitution on the aromatic ring generally increased the affinity for sigma(2) receptors while maintaining a similar affinity for sigma(1) receptors. Substitution with electron-donating groups, such as OH, OMe, or NH2, resulted in weak or negligible affinity for sigma(2) receptors and a moderate affinity for sigma(1) receptors. The 2-fluoro-substituted analogue, 11, exhibited the highest selectivity for sigma(1) receptors among all compounds tested, with a K-i value of 3.56 nM for sigma(1) receptors and 667 nM for sigma(2) receptors. Compounds 1, 5, 9, 11, and 20 had no affinity for dopamine D-2 (IC50 > 10 000 nM) and D-3 (IC50 > 10 000 nM) receptors. The nanomolar binding affinity and high selectivity for sigma(1) receptors suggest that these compounds may be developed as potential radiotracers for positron emission tomography or single photon emission computerized tomography imaging studies.
• SELECTIVE CELLULAR TARGETING: MULTIFUNCTIONAL DELIVERY VEHICLES
  申请人：Drug Innovation & Design, Inc.

  公开号：EP1255567A1

  公开（公告）日：2002-11-13
• US7041667B1
  申请人：——

  公开号：US7041667B1

  公开（公告）日：2006-05-09